Pfizer Inc. saw its stock fall despite beating Wall Street’s expectations for fourth-quarter revenue and profit. The company reported a net income of $410 million, or 7 cents a share, reversing a loss of $3.37 billion in the same quarter last year. Analysts expect Pfizer’s growth to accelerate, with the firm predicting increased focus on innovative drugs and vaccines.
Source: https://www.marketwatch.com/story/pfizer-stock-climbs-on-q4-revenue-and-earnings-beat-reaffirmed-guidance-4bb4a3e6